Valuation: Illumina, Inc.

Market Cap 33.97B 29.11B 27.28B 24.92B 47.02B 3,239B 47.49B 322B 125B 1,634B 128B 125B 5,412B P/E 2026 *
45.5x
P/E 2027 * 38.5x
Enterprise Value 34.22B 29.32B 27.48B 25.1B 47.36B 3,262B 47.83B 324B 126B 1,646B 128B 126B 5,451B EV / Sales 2026 *
7.4x
EV / Sales 2027 * 6.77x
Free-Float
74.98%
Yield 2026 *
-
Yield 2027 * -
1 day+0.79%
1 week+19.49%
Current month+9.70%
1 month+15.92%
3 months+55.80%
6 months+84.61%
Current year+71.54%
1 week 200.3
Extreme 200.302
226.84
1 month 186.64
Extreme 186.64
226.84
Current year 112.65
Extreme 112.65
226.84
1 year 88
Extreme 88
226.84
3 years 68.7
Extreme 68.7
226.84
5 years 68.7
Extreme 68.7
477.16
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer 55 28/05/2025
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap.
21/08/26
Corvex Management LP
SellCompany -299,336 0.1978%
19/08/26 Other

Director

0 0%
18/08/26 Sell

Executive/Senior Manager

-1,033 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+0.79%+19.49%+125.76%+42.33% 33.97B
-0.09%+6.64%+28.00%+15.98% 232B
+0.40%+8.21%+3.97%-15.48% 152B
-0.46%-4.94%-20.62%+24.97% 131B
+1.73%-1.21%-52.56%-1.77% 72.26B
-1.71%+0.61%-16.49%-12.61% 51.57B
+0.41%-0.12%+12.38%+19.30% 52.38B
+0.87%+4.26%+29.90%+29.32% 43.71B
+0.90%+3.29%+38.63%+51.60% 40.72B
+1.78%+7.55%-17.22%+46.97% 34.13B
Average +0.36%+4.06%+13.17%+20.06% 84.42B
Weighted average by Cap. +0.22%+3.79%+8.25%+13.38%

Financials

2026 *2027 *
Net sales 4.62B 3.96B 3.71B 3.39B 6.4B 441B 6.46B 43.8B 17.05B 222B 17.36B 16.99B 737B 4.91B 4.21B 3.94B 3.6B 6.8B 468B 6.86B 46.51B 18.11B 236B 18.44B 18.04B 782B
Net income 760M 652M 610M 558M 1.05B 72.49B 1.06B 7.2B 2.8B 36.57B 2.85B 2.79B 121B 891M 764M 716M 654M 1.23B 84.97B 1.25B 8.44B 3.29B 42.87B 3.35B 3.27B 142B
Net Debt 246M 211M 198M 180M 341M 23.45B 344M 2.33B 907M 11.83B 924M 904M 39.19B -729M -625M -585M -535M -1.01B -69.5B -1.02B -6.9B -2.69B -35.06B -2.74B -2.68B -116B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
25/08/26 US$224.99 +0.79% 1,918,113
24/08/26 US$223.22 +1.74% 2,250,988
21/08/26 US$219.40 +2.89% 1,917,222
20/08/26 US$213.24 +4.02% 3,284,715
19/08/26 US$205.00 +8.87% 2,090,865
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
224.99USD
Average target price
198.89USD
Spread / Average Target
-11.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock